Pathstone Holdings’s Surgery Partners SGRY Stock Holding History

Pathstone Holdings’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,948	Closed	-$410K	–	2369
2025 Q3	$410K	Sell	18,948 -2,315	-11%	-$51.6K	﹤0.01%	1869
2025 Q2	$473K	Sell	21,263 -27,029	-56%	-$601K	﹤0.01%	1746
2025 Q1	$1.15M	Buy	48,292 +23,459	+94%	+$555K	0.01%	1304
2024 Q4	$526K	Sell	24,833 -32,514	-57%	-$853K	﹤0.01%	1699
2024 Q3	$1.85M	Buy	57,347 +13,534	+31%	+$400K	0.01%	1022
2024 Q2	$1.04M	Buy	43,813 +11,457	+35%	+$294K	﹤0.01%	1308
2024 Q1	$965K	Buy	32,356 +17,808	+122%	+$557K	﹤0.01%	1299
2023 Q4	$465K	Buy	+14,548	New	+$422K	﹤0.01%	1551

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Pathstone Holdings's SGRY Position: Q4 2025 in Review

Pathstone Holdings sold out of Surgery Partners (SGRY) in Q4 2025, closing a stake of 18,948 shares — an estimated $410K sold.

Pathstone Holdings first reported a position in SGRY in Q4 2023 and held it in 8 quarters. The position peaked at $1.85M in Q3 2024. 181 funds tracked by Wall St. Rank hold SGRY as of Q4 2025.

Pathstone Holdings reported no remaining Surgery Partners position as of Q4 2025 after selling out during the quarter.
Pathstone Holdings sold 18,948 Surgery Partners shares in Q4 2025, an estimated $410K.
Pathstone Holdings first reported a position in Surgery Partners in Q4 2023 and held it in 8 quarters.
Pathstone Holdings's Surgery Partners position peaked at $1.85M in Q3 2024.
181 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2025.

Based on Pathstone Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.